Objective : The aim of this study was to repopulate decellularized heart valve matrices with ovine mesenchymal stem cells (oMSCs) by the use of platelet gel (PG) supernatant, a storage vehicle for growth factors. Methods : oMSCs were exposed to different concentrations of PG-released supernatant and cell proliferation was evaluated using the MTS assay. oMSC motility and invasiveness were assayed using a Boyden chamber. A quantitative sandwich enzyme immunoassay was used to examine amounts of bFGF and TGF-beta 1 in the PG supernatant. Repopulation of acellular heart valve matrices was stimulated by seeding matrices with oMSCs supplemented with the PG supernatant. Results : The most significant increase in proliferation induced by PG supernat...
Objectives: Incubating a porcine aortic valve matrix with a platelet gel (PG) concentrate creates a ...
ObjectivesThis study sought to investigate the combination of transcatheter aortic valve implantatio...
This project aimed to design a growth factor environment to mitigate cellular contraction in TEHVs. ...
Objectives: Platelet gel (PG), a storage vehicle of growth factors, can be considered for the applic...
Background: Platelet-gel (PG) as a storage vehicle of growth factors, can be considered for the appl...
Growth factors that regulate proliferation, migration, and invasion of ovine mesenchymal stem cells ...
Tissue-engineered heart valves represent a promising strategy for the growing need for valve replace...
Background: Vascular smooth muscle cells (VSMCs) are a potential autologous cell source for aortic v...
Introduction: The use of bioprosthetic valves avoids the necessity of warfarinisation, but they ofte...
BackgroundAutologous recellularization of decellularized heart valve scaffolds is a promising challe...
Aortic heart valve disease is a growing health problem and a tissue-engineered aortic heart valve co...
Calcification risk and immune response are reduced after cardiac valve decellulariztion and subseque...
Tissue engineering aims to develop viable tissue constructs that mimic native tissues by seeding cel...
Background Platelet gel is used to facilitate wound healing in virtue of the growth factors released...
Aortic heart valve disease is a growing health problem and a tissue-engineered aortic heart valve co...
Objectives: Incubating a porcine aortic valve matrix with a platelet gel (PG) concentrate creates a ...
ObjectivesThis study sought to investigate the combination of transcatheter aortic valve implantatio...
This project aimed to design a growth factor environment to mitigate cellular contraction in TEHVs. ...
Objectives: Platelet gel (PG), a storage vehicle of growth factors, can be considered for the applic...
Background: Platelet-gel (PG) as a storage vehicle of growth factors, can be considered for the appl...
Growth factors that regulate proliferation, migration, and invasion of ovine mesenchymal stem cells ...
Tissue-engineered heart valves represent a promising strategy for the growing need for valve replace...
Background: Vascular smooth muscle cells (VSMCs) are a potential autologous cell source for aortic v...
Introduction: The use of bioprosthetic valves avoids the necessity of warfarinisation, but they ofte...
BackgroundAutologous recellularization of decellularized heart valve scaffolds is a promising challe...
Aortic heart valve disease is a growing health problem and a tissue-engineered aortic heart valve co...
Calcification risk and immune response are reduced after cardiac valve decellulariztion and subseque...
Tissue engineering aims to develop viable tissue constructs that mimic native tissues by seeding cel...
Background Platelet gel is used to facilitate wound healing in virtue of the growth factors released...
Aortic heart valve disease is a growing health problem and a tissue-engineered aortic heart valve co...
Objectives: Incubating a porcine aortic valve matrix with a platelet gel (PG) concentrate creates a ...
ObjectivesThis study sought to investigate the combination of transcatheter aortic valve implantatio...
This project aimed to design a growth factor environment to mitigate cellular contraction in TEHVs. ...